AstraZeneca: The Journey to Becoming the UK’s First £200 Billion Company
AstraZeneca recently became the first UK company to reach a £200 billion market valuation, driven by its groundbreaking cancer treatments and strategic vision under CEO Pascal Soriot. This milestone sets a new benchmark for innovation and growth in the UK economy.
